1,002
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA TTTY15 silencing inhibits gastric cancer progression by sponging microRNA-98-5p to down-regulate cyclin D2 expression

, &
Pages 7380-7391 | Received 26 Nov 2021, Accepted 23 Feb 2022, Published online: 10 Mar 2022

References

  • Rong GH, Zhang YX, Ma YC, et al. The Clinical and molecular characterization of gastric cancer patients in Qinghai-Tibetan plateau. Front Oncol. 2020;10:1033.
  • Zhao QF, Cao L, Guan LL, et al. Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics. 2019;18(2):107–112.
  • Correa P, Piazuelo MB, and Camargo MC. The future of gastric cancer prevention. Gastric Cancer 2004;73:9–16.
  • Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67.
  • Lu SH, Zhang J, Lian XL, et al. A hidden human proteome encoded by ‘non-coding’ genes. Nucleic Acids Res. 2019;47(15):8111–8125.
  • Wang JC, Su ZL, Lu SN, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–233.
  • Wang JY, Lu AQ, Chen LJ. LncRNAs in ovarian cancer. Clin Chim Acta. 2019;490:17–27.
  • Logotheti S, Marquardt S, Gupta SK, et al. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during bladder cancer progression as target and co-activator of E2F1. Theranostics. 2020;10(21):9620–9643.
  • Liu XJ, Li SL, Li JS, et al. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis. Eur Rev Med Pharmacol Sci. 2018;22(9):2624–2630.
  • Zhuang M, Gao W, Xu J, et al. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448:315–322.
  • Wang W, Yang JB. Long noncoding RNA TTTY15 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging microRNA-337-3p to upregulate the expression of JAK2. Anticancer Drugs. 2020;31(10):1038–1045.
  • Zheng X-YX-Y, Cao MZ, Ba Y, et al. LncRNA testis-specific transcript, Y-linked 15 (TTTY15) promotes proliferation, migration and invasion of colorectal cancer cells via regulating miR-29a-3p/DVL3 axis. Cancer Biomark. 2021;31(1):1–11.
  • Xiao GA, Ao JJ, Kong DP, et al. The long moncoding RNA TTTY15, which is located on the Y chromosome, promotes prostate cancer progression by sponging let-7. Eur Urol. 2019;76(3):315–326.
  • Lai IL, Chang YS, Chan WL, et al. Male-specific long noncoding RNA TTTY15 inhibits non-small cell lung cancer proliferation and metastasis via TBX4. Int J Mol Sci. 2019;20(14):3473.
  • Vienberg S, Geiger J, and Madsen S, et al. MicroRNAs in metabolism. Acta Physiol (Oxf). 2017;219(2):346–361.
  • Wang F, Liang R, Tandon N, et al. H19X-encoded miR-424(322)/-503 cluster: emerging roles in cell differentiation, proliferation, plasticity and metabolism. Cell Mol Life Sci. 2019;76(5):903–920.
  • Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353(17):1793–1801.
  • Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944–13949.
  • Sabit H, Cevik E, Tombuloglu H, et al. Triple negative breast cancer in the era of miRNA. Crit Rev Oncol Hematol. 2021;157:103196.
  • Du XH, Zhang JT, Wang JP, et al. Role of miRNA in lung cancer-potential biomarkers and therapies. Curr Pharm Des. 2018;23(39):5997–6010.
  • Fabris L, Ceder Y, and Chinnaiyan AM, et al. The potential of microRNAs as prostate cancer biomarkers. Eur Urol 2016;70(2) :312–322.
  • Ghafouri-Fard S, Shoorei H, Taher M. miRNA profile in ovarian cancer. Exp Mol Pathol. 2020;113:104381.
  • Zeng L, Liao Q, Zeng X, et al. Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered. 2022;13(2):2623–2638.
  • Gao M, Li W, Wang H, et al. The distinct expression patterns of claudin-10, −14, −17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues. Diagn Pathol. 2013;8(1):205.
  • Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–D97.
  • Riffo-Campos ÁL, Riquelme I, Brebi-Mieville P. Tools for Sequence-Based miRNA Target Prediction: what to Choose? Int J Mol Sci. 2016;17:1987.
  • Yu L, Qu H, Yu Y, et al. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med. 2018;22(12):6134–6147.
  • Chen B, Wang H, Lv C, et al. Long non-coding RNA H19 protects against intracerebral hemorrhage injuries via regulating microRNA-106b-5p/acyl-CoA synthetase long chain family member 4 axis. Bioengineered. 2021;12(1):4004–4015.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
  • Kumar P, Nagarajan A, and Uchil PD. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc. 2018;2018(6): 469–471.
  • Telford WG. Multiparametric Analysis of Apoptosis by Flow Cytometry. Methods Mol Biol. 2018;1678:167–202.
  • Ren H, Li Z, Tang Z, et al. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis. J Cell Physiol. 2020;235(5):4824–4833.
  • Kim B. Western blot Techniques. Methods Mol Biol. 2017;1606:133–139.
  • Zheng J, Zhuo YY, Zhang C, et al. LncRNA TTTY15 regulates hypoxia-induced vascular endothelial cell injury via targeting miR-186-5p in cardiovascular disease. Eur Rev Med Pharmacol Sci. 2020;24(6):3293–3301.
  • Chen YQ, Yang X, Xu W, et al. Knockdown of lncRNA TTTY15 alleviates myocardial ischemia–reperfusion injury through the miR-374a-5p/FOXO1 axis. IUBMB Life. 2021;73(1):273–285.
  • Huang SQ, Ao WQ, Guo ZF, et al. Suppression of long noncoding RNA TTTY15 attenuates hypoxia-induced cardiomyocytes injury by targeting miR-455-5p. Gene. 2019;701:1–8.
  • Hao CG, Chen SB. Knockdown of lncRNA TTTY15 alleviates ischemia/reperfusion-induced inflammation and apoptosis of PC12 cells by targeting miR-766-5p. Exp Ther Med. 2021;21(5):511.
  • Zhang H, Zou XF, Liu F. Silencing TTTY15 mitigates hypoxia-induced mitochondrial energy metabolism dysfunction and cardiomyocytes apoptosis via TTTY15/let-7i-5p and TLR3/NF-κB pathways. Cell Signal. 2020;76:109779.
  • Liang F, Yu QH, Chu Y, et al. MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1. Int J Oncol. 2019;54(1):128–138.
  • Zhan PP, Shu X, Chen M, et al. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. Life Sci. 2021;276:119405.
  • Li YB, Wang XR, Zhao ZH, et al. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1. Biosci Rep. 2021;41(7):BSR20200767.
  • Niu XY, Yang B, Liu F, et al. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. Biomed Pharmacother. 2020;121:109623.
  • Dong LN, Cao XJ, Luo Y, et al. A Positive Feedback Loop of lncRNA DSCR8/miR-98-5p/STAT3/HIF-1α Plays a Role in the Progression of Ovarian Cancer. Front Oncol. 2020;10:1713.
  • Qiu K, Xie QJ, Jiang S, et al. miR-98-5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase-3 by HMGA2. J Clin Lab Anal. 2020;34(2):e23044.
  • Xu QF, Peng HP, Lu XR, et al. Oleanolic acid regulates the Treg/Th17 imbalance in gastric cancer by targeting IL-6 with miR-98-5p. Cytokine. 2021;148:155656.
  • Hille S, Dierck F, Kühl C, et al. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling. Cardiovasc Res. 2016;110(3):381–394.
  • Wang J, Shu HZ, Guo SG. MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2. Cancer Med. 2020;9(12):4360–4370.
  • Park SY, Lee CJ, Choi JH, et al. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance. J Exp Clin Cancer Res. 2020;38(1):399.
  • Zhao CC, Liu J, Wu HZ, et al. Aberrant methylation-mediated downregulation of lncRNA CCND2 AS1 promotes cell proliferation in cervical cancer. J Biol Res (Thessalon). 2020;27(1):11.
  • Jin M, Ren J, Luo M, et al. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2. Carcinogenesis. 2020;41(5):634–645.
  • Zhong H, Yang J, Zhang B, et al. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2. Cancer Biomark. 2018;22(4):787–797.
  • Zhuo SS, Sun MM, Bai RM, et al. Long intergenic non-coding RNA 00473 promotes proliferation and migration of gastric cancer via the miR-16-5p/CCND2 axis and by regulating AQP3. Cell Death Dis. 2021;12(5):496.